@misc{indiciaec5f6000fa0c5,
  title = {RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP trafficking.},
  author = {Gad, S. A. and Hussein, S. A. and Fukano, K. and Kato, T. and Shoji, I. and Chayama, K. and Muramatsu, M. and Isogawa, M. and Wakita, T. and Merk, D. and Aly, H. H.},
  year = {2025},
  doi = {10.1101/2025.04.21.649881},
  url = {https://www.biorxiv.org/content/10.1101/2025.04.21.649881v1},
  note = {Source identifier: 10.1101/2025.04.21.649881}
}